Table 1.
Characteristic | HDS users (n = 5456)* | HDS nonusers (n = 20,086)* |
---|---|---|
Age† | ||
18–24 | 11% | 13% |
25–44 | 41% | 38% |
45–64 | 37% | 31% |
≥65 | 11% | 18% |
Race/Ethnicity† | ||
Asian | 5% | 3% |
Hispanic | 8% | 9% |
Non-Hispanic black | 9% | 12% |
Non-Hispanic white | 79% | 75% |
Female† | 58% | 51% |
Education† | ||
<High school | 8% | 18% |
High school graduate | 57% | 60% |
College or higher | 35% | 23% |
Family Income† | ||
0–19,999 | 16% | 21% |
20,000–44,999 | 28% | 31% |
45,000–74,999 | 24% | 23% |
≥75,000 | 32% | 25% |
Region† | ||
Northeast | 20% | 19% |
Midwest | 23% | 25% |
South | 32% | 38% |
West | 25% | 17% |
Currently married | 59% | 58% |
Foreign-born | 13% | 13% |
Among foreign-born, years in US | ||
<5 | 13% | 16% |
5–10 | 13% | 15% |
≥10 | 74% | 69% |
Uninsured | 14% | 15% |
Has access to conventional care | 87% | 87% |
Self-rated health† | ||
Good or better | 90% | 88% |
Chronic conditions | ||
Rheumatologic† | 24% | 20% |
Oncologic | 8% | 7% |
Cardiac‡ | 42% | 39% |
Vascular | 10% | 10% |
Pulmonary† | 14% | 11% |
Gastrointestinal† | 15% | 11% |
Neurologic | 3% | 3% |
Endocrine | 13% | 13% |
Number of chronic conditions† | ||
0 | 37% | 44% |
1 | 25% | 22% |
≥2 | 37% | 34% |
Prescription medication use† | 73% | 66% |
Percents were weighted to reflect national estimates.
p < 0.001.
p < 0.05.